Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
4.2K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K
Complexometric Titration: Ligands00:43

Complexometric Titration: Ligands

2.2K
Different monodentate and polydentate ligands are used as complexing agents in complexometric titration reactions. The formation of complexes by mono- and bidentate ligands involves two or more intermediate steps, limiting their use as complexing agents. In comparison, polydentate ligands can form complexes with metal ions in a single-step process, facilitating sharper end points. This means polydentate ligands, such as amino carboxylic acid derivatives, are most commonly employed in...
2.2K
Ligand Binding Sites02:40

Ligand Binding Sites

14.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Controlling metal-carbonate phase, form, and function through de novo protein design.

bioRxiv : the preprint server for biology·2026
Same author

Systems-Scale Structural Modeling Reveals the Germline Architecture of Immunodominance.

bioRxiv : the preprint server for biology·2026
Same author

Generative design of programmable asymmetric β-barrel nanopores.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: De novo design of quasisymmetric two-component protein cages.

Nature·2026
Same author

De novo design of miniproteins targeting GPCRs.

Nature·2026
Same author

De novo design of quasisymmetric two-component protein cages.

Nature·2026

相关实验视频

Updated: Jan 11, 2026

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.2K

对pH敏感结合剂的计算设计.

Green Ahn1,2,3, Brian Coventry1,2,3, Ella Haefner1,2

  • 1Institute for Protein Design, University of Washington, Seattle, WA, USA.

bioRxiv : the preprint server for biology
|November 19, 2025
PubMed
概括
此摘要是机器生成的。

科学家们开发了计算方法来设计pH依赖的蛋白质结合剂. 这些结合剂可以被设计为在酸性pH值下减弱或破坏稳定,从而为癌症等疾病提供新的治疗策略.

更多相关视频

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

10.3K
Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
11:38

Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores

Published on: April 5, 2022

3.0K

相关实验视频

Last Updated: Jan 11, 2026

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

8.2K
Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
09:33

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor

Published on: March 21, 2018

10.3K
Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores
11:38

Quantifying the Binding Interactions Between CuII and Peptide Residues in the Presence and Absence of Chromophores

Published on: April 5, 2022

3.0K

科学领域:

  • 生物化学和分子生物学
  • 蛋白质工程是指蛋白质工程.
  • 治疗开发的治疗方法

背景情况:

  • 生理学pH梯度在生物过程中至关重要,包括囊泡运输和瘤微环境.
  • 创建pH依赖结合物的现有方法是经验性的,劳动密集型的,缺乏可预测性.
  • 准pH值变化为开发新疗法提供了一个有前途的途径.

研究的目的:

  • 为设计pH依赖蛋白质结合剂引入新的计算原理.
  • 为了创建可以通过pH调节的结合剂,用于治疗应用.
  • 为了证明这些结合剂在降解特定蛋白质标中的有效性.

主要方法:

  • 使用两个计算原理设计了pH依赖的结合剂:在接口处的静电排斥和通过埋藏的histidine网络的不稳定.
  • 引入了与正电荷相邻的histidine残留物,以削弱低pH时的结合.
  • 嵌入埋藏的含有histidine的结网,以在酸性条件下破坏蛋白质结构的稳定.

主要成果:

  • 成功设计了在酸性pH值下与多个标分离的结合剂:以林A型受体2,瘤亡因子受体2,白素-6,蛋白转化酶亚素/素类型9和Neo2.
  • 通过将设计的结合剂与溶酶体贩运受体融合而制造的催化降解剂.
  • 通过使用这些催化降解剂,在substoichiometric水平实现了目标降解.

结论:

  • 描述的计算方法为设计pH敏感蛋白疗法提供了一个合理的方法.
  • 这些依赖pH的结合剂和催化降解剂在各种生理环境中广泛适用于调节蛋白质活性.
  • 这些发现为开发下一代基于蛋白质的疗法铺平了道路,利用pH梯度.